Edition:
United Kingdom

Mitsubishi Tanabe Pharma Corp (4508.T)

4508.T on Tokyo Stock Exchange

2,351JPY
17 Nov 2017
Change (% chg)

¥-32 (-1.34%)
Prev Close
¥2,383
Open
¥2,353
Day's High
¥2,365
Day's Low
¥2,338
Volume
1,724,100
Avg. Vol
1,109,152
52-wk High
¥2,748
52-wk Low
¥2,073

Summary

Name Age Since Current Position

Masayuki Mitsuka

62 2015 Executive President, President, Representative Director

Hiromi Okatake

2017 Chief Compliance Officer, Executive Officer, Director of Legal Affairs & Intellectual Property

Takashi Kobayashi

61 2017 Senior Managing Executive Officer, Chief Director of CMC, Representative Director

Yoshiaki Ishizaki

62 2016 Managing Executive Officer, Chief Director of Sales, Director

Seiichi Murakami

60 2017 Managing Executive Officer, Chief Director of Drug Fostering & Evolution, Director

Eizo Tabaru

59 2017 Managing Executive Officer, Director

Takashi Tanaka

60 2017 Managing Executive Officer, Chief Director of Pharmaceutical, Director

Kuniyoshi Wada

2015 Managing Executive Officer

Shigeru Doseki

2017 Executive Officer, Deputy Chief Director of Sales, Manager of Tokyo Office

Katsuaki Kitayama

2017 Executive Officer, Deputy Chief Director of Sales

Mikio Himizu

2017 Executive Officer, Deputy Chief Director of Drug Discovery

Kazutaka Kawashima

2017 Executive Officer, Director of Portfolio Management

Yoshihiro Kobayashi

2017 Executive Officer, Deputy Chief Director of Drug Fostering & Evolution

Eiji Tanaka

Executive Officer, President of Subsidiary

Hiroaki Ueno

2017 Executive Officer, Chief Director of Drug Discovery

Shigehiko Hattori

76 2011 Independent Director

Shigeki Iwane

64 2016 Independent Director

Tsutomu Kamijo

63 2017 Independent Director

Toshihide Doi

2017 Director of Accounting & Finance

Biographies

Name Description

Masayuki Mitsuka

Mr. Masayuki Mitsuka has been serving as Executive President, President and Representative Director in Mitsubishi Tanabe Pharma Corporation since October 2015. He is also serving as Director in The KAITEKI Institute, Inc. and its parent company, Mitsubishi Chemical Holdings Corporation. He used to work for three other companies, including ZOEGENE Corporation.

Hiromi Okatake

Takashi Kobayashi

Mr. Takashi Kobayashi has been serving as Senior Managing Executive Officer, Chief Director of CMC and Representative Director in Mitsubishi Tanabe Pharma Corporation since April 1, 2017. He joined the Company in April 1980. His previous titles include Managing Executive Officer, Chief Director of Research, Director of Business Administration and Chief Director of Drug Discovery in the Company.

Yoshiaki Ishizaki

Mr. Yoshiaki Ishizaki has been serving as Managing Executive Officer, Chief Director of Sales and Director in Mitsubishi Tanabe Pharma Corporation since January 2016. His previous titles include Executive Officer Chief Director of Reliability Guarantee, Chief Compliance Officer and Director of Sales Promotion in Main Sales Unit in the Company. He used to work for another company.

Seiichi Murakami

Mr. Seiichi Murakami has been serving as Managing Executive Officer, Chief Director of Drug Fostering & Evolution and Director in Mitsubishi Tanabe Pharma Corporation since April 1, 2017. He joined the Company in April 1980. His previous titles include Executive Officer, Director of 1st Medical Affairs, Chief Director of Sales, Chief Director of Development and Director of Development Planning in the Company.

Eizo Tabaru

Mr. Eizo Tabaru has been serving as Managing Executive Officer and Director in Mitsubishi Tanabe Pharma Corporation since April 2017. He used to work for Mitsubishi Chemical Corporation and another company.

Takashi Tanaka

Mr. Takashi Tanaka has been serving as Managing Executive Officer, Chief Director of Pharmaceutical and Director in Mitsubishi Tanabe Pharma Corporation since June 2017. He joined the Company in April 1985. His previous titles include Executive Officer, Director of Pharmaceutical Planning, Director of Production Planning in Main Production Unit and Deputy Chief Director of CMC in the Company.

Kuniyoshi Wada

Shigeru Doseki

Katsuaki Kitayama

Mikio Himizu

Kazutaka Kawashima

Yoshihiro Kobayashi

Eiji Tanaka

Hiroaki Ueno

Shigehiko Hattori

Mr. Shigehiko Hattori has been serving as Independent Director in Mitsubishi Tanabe Pharma Corporation since June 2011. He is also serving as Independent Director in Sapporo Holdings Limited, Brother Industries, Ltd. and Meiji Yasuda Life Insurance Company. He used to work for Shimadzu Corporation.

Shigeki Iwane

Mr. Shigeki Iwane has been serving as Independent Director in Mitsubishi Tanabe Pharma Corporation since June 2016. He is also serving as President and Representative Director in The Kansai Electric Power Company, Incorporated. He used to work for Kinden Corporation.

Tsutomu Kamijo

Mr. Tsutomu Kamijo has been serving as Independent Director in Mitsubishi Tanabe Pharma Corporation since June 2017. He is also serving as Chairman of the Board and Representative Director in Sapporo Holdings Limited.

Toshihide Doi